August - 2022

News

How Israeli technology saved 78-year-old Leah from skin cancer

Alpha-emitting Radiation Therapy Could Create a Paradigm Shift in Cancer Treatment

Alpha DaRT treatment proves a success in first-in-human trial

Israel's alpha radiation treatment shows tumor shrinkage in 100% of cases

Alpha Tau Announces the Publication of Exceptional Clinical Data from Alpha DaRT, its Novel Alpha Ra

Israeli MedTech Start-up, Alpha Tau Medical, Raises $29 Million in Private Financing to Cure Cancer

Alpha Tau’s High-Precision Cancer Radiotherapy Receives Radioactive-Safety Approval in the United St

First Alpha Tau Medical Summit Gathers Over 200 Oncologists and Physicians From all Around the World

Aug 31, 2022

Alpha Tau Medical to Participate in Upcoming September Investor Conferences

JERUSALEM, August 30, 2022 -- Alpha Tau Medical Ltd. (Nasdaq: DRTS) ("Alpha Tau"), the developer of the innovative alpha-radiation cancer...

Aug 26, 2022

Alpha Tau Medical Announces Second Quarter 2022 - Financial Results and Provides Corporate Update

-Received FDA Conditional Investigational Device Exemption (IDE), whose conditions have since been satisfied, to initiate a pivotal trial...

Aug 22, 2022

Alpha Tau and MIM Software Announce Collaboration for Alpha DaRT Treatment Planning

JERUSALEM and CLEVELAND, Aug. 22, 2022 -- Today, Alpha Tau Medical Ltd. (Nasdaq: DRTS) ("Alpha Tau"), the developer of the innovative...